Mobile
browsing
RMB8.9million
Healthcare & elderly care
Heze
Joint capital and cooperation
At present, the project is making preparatory work and the relevant procedures are being handled.
The project has a total construction area of 200,000 square meters. It is planned to build a research and development testing center withe supporting scientific research equipment. There will be 10 production workshops, 4 raw material warehouses, 4 finished product warehouses, 10 production lines (inclusive of equipment and supporting facilities), one office building and one dormitory building.
After the completion of the project, a total of about 200 tons of pharmaceutical intermediates such as 9-hydroxy AD (about 70 tons), high-purity L- tert-leucine (about 60 tons) and cytarabine (about 70 tons) can be produced annually, which will occupy 80% of the national market share and be mainly sold to the United States, India, South Korea, Singapore and other countries. The products will take an important step in the research and industrialization of high-purity pharmaceutical intermediates. It is estimated that the annual sales revenue will be about RMB 3.5 billion, the profit about RMB 380 million, and the profit and tax about RMB 200 million.
Wang Xingwen and Liu Fuhai 0530-6226266